Effect of Oral Hypoglycemics in Combinatio
Phase 4
Completed
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2018/03/012561
- Lead Sponsor
- SRM College of Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with Type 2 diabetes mellitus
HbA1C Greater than or Equal to 6.5 %
eGFR Greater than or Equal to 60 ml/min
Patients willing to give informed consent
Exclusion Criteria
Patients with CKD (stage 3 and above) or on dialysis
Patients with Type 1 diabetes mellitus
Pregnancy/Lactating Women
Acute Liver disease
Diabetic ketoacidosis
Patients with Psychiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c <br/ ><br>Post Prandial Blood Glucose Fasting Blood Glucose and Glycaemic Variability TestTimepoint: After 12 Weeks
- Secondary Outcome Measures
Name Time Method ADRsTimepoint: Every 4 Weeks